C83.77 Burkitt lymphoma, spleen

Name of the Condition

• Burkitt lymphoma, spleen
• Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. This subtype specifically involves the spleen. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

• Epstein-Barr virus (EBV) infection
• Human immunodeficiency virus (HIV) infection
• Weakened immune system from other conditions or treatments
• Young age, especially in children and young adults
• Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

• Rapidly growing, painless lymph node swelling
• Abdominal pain or swelling (if lymphoma affects the abdomen)
• Fever
• Night sweats
• Unexplained weight loss
• Fatigue
• Possible splenomegaly (enlarged spleen) leading to discomfort or early satiety

Diagnosis

Diagnosis involves a physical examination to assess lymph node or organ swelling, followed by imaging tests (e.g., CT or MRI) to identify tumor locations. A biopsy of affected tissue is performed to confirm the presence of cancerous cells. Laboratory tests, including blood work and possibly bone marrow aspiration, may also be used to evaluate disease extent.

Treatment Options

Treatment typically involves intensive chemotherapy regimens, often including combinations of drugs like cyclophosphamide, vincristine, and prednisone. In some cases, targeted therapies or immunotherapy may be considered. Treatment plans are tailored to the patient's overall health and disease stage.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for Burkitt lymphoma can be favorable, especially in younger patients. However, the aggressive nature of the disease requires close monitoring. Follow-up care includes regular imaging and blood tests to check for recurrence and manage potential long-term effects of treatment.

Complications

Potential complications include tumor lysis syndrome, a condition where rapid cell death releases harmful substances into the blood. Other risks include infection due to weakened immunity, organ damage from the tumor, and side effects from treatment such as nausea, fatigue, or neuropathy.

Lifestyle & Prevention

While prevention is not always possible, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (like untreated HIV) may help reduce susceptibility. Avoiding exposure to EBV is not practical for most, but awareness of symptoms can aid early detection.

When to Seek Professional Help

Seek medical attention if you experience persistent, unexplained lymph node swelling, unexplained weight loss, fever, or abdominal pain. Early evaluation is crucial for conditions like Burkitt lymphoma, which progresses rapidly.

Tips for Medical Coders

When coding for Burkitt lymphoma of the spleen (C83.77), ensure documentation specifies the spleen as the primary site. Verify that the diagnosis aligns with clinical findings and that any relevant staging or treatment details are clearly recorded. Accurate site specification is essential for correct code assignment.